Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-05-19

Clinical Trial Update: NAPLS Omega-3 Fatty Acid Versus Placebo Study [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating omega-3 fatty acids versus placebo for psychosis has completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NAPLS Omega-3 Fatty Acid (omega-3 fatty acids)

Snippet

Sponsor: University of California, San Diego | Conditions: Psychosis | Phase 1 | Status: COMPLETED | Results posted: 2020-05-19